T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expression

Viral Immunology

Volumn 9, Issue 3, 1996, Pages 187-194

  Baroja, Miren L ^a,b   Sirit, Firelei L ^a   Rivera, Henry ^a   Garzaro, Jenny ^a   Bianco, Nicolas E ^a   Machado, Irma V ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Instituto de Inmunologia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; OKT 3; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MALE; MONOCYTE; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS CARRIER;

HEPATITIS B VIRUS;

EID: 0029828731     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.187     Document Type: Article

References (23)

1. Baker, B.L., M. Di Bisceglie, S. Kaneko, R. Miller, S.M. Waggoner, and J.G. Hoofnagle. 1991. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology 13:632-636.
2. Baroja, M.L., F.L. Sirit, D.J. Caldera, F.I. Toro, M.E. Zabaleta, C.J. Colmenares, N.E. Bianco, and I.V. Machado. 1993. Anti-CD3 activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signals. Clin. Immunol. Immunopathol. 69:180-188.
3. Carman, R.D., K.A. Jacobs, S.C. Clark, and D.H. Raulet. 1987. B cell-stimulatory factor 2 (beta-2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc. Natl. Acad. Sci. U.S.A. 84:7629-7633.
4. Ceuppens, J.L., M.L. Baroja, K. Lorré, J. Van Damme, and A. Billiau. 1988. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J. Immunol. 141:3868-3874.
5. Ferrari, C., A. Penna, A. Cavalli, A. Bertoletti, A. Valli, G. Missale, M. Pilli, T. Giuberti, and F. Fiaccadori. 1991. Human cellular immune responses to hepatitis B virus (HBV) envelope and nucleocapsid antigens, pp. 238-243. In F. Blaine-Hollinger, S.M. Lemon, and H.S. Margolis (eds.), Viral Hepatitis and Liver Diseases. Williams & Wilkins, Baltimore.
6. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149-1157.
7. Hirata, Y., T. Taga, M. Hibi, N. Nakano, T. Hirano, and T. Kishimoto. 1989. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol. 143:2900-2906.
8. Honda, M., S. Yamamoto, M. Cheng, K. Yasukawa, H. Suzuki, T. Saito, Y. Osugi, T. Tokunaga, and T. Kishimoto. 1992. Human soluble IL-6 receptors: Its detection and enhanced release by HIV infection. J. Immunol. 148:2175-2180.
9. Jung, M.C., H.M. Diepolder, and G.R. Pape. 1994. T cell recognition of hepatitis B and C viral antigens. Eur. J. Clin. Invest. 24:641-650.
10. Kaneko, S., R.H. Miller, S.M. Feinstone, M. Unoura, K. Kobayashi, R. Hattori, and R.H. Purcell. 1989. Detection of serum hepatitis B DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc. Natl. Acad. Sci. U.S.A. 86:312-316.
11. Kuhweide, R., J. Van Damme, K. Lorré, M.L. Baroja, M. Tsudo, and J.L. Ceuppens. 1990. Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2 responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1. Cytokine 2:45-54.
12. Lorré, K., J. Van Damme, J. Verwilghen, M.L. Baroja, and J.L. Ceuppens. 1990. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. J. Immunol. 144:4681-4687.
13. Lotz, M., F. Jirik, P. Kabouridis, C. Tsoukas, T. Hirano, T. Kishimoto, and D.A. Carson. 1988. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167:1253-1258.
14. Mackiewicz, A., H. Schooltink, P.C. Heinrich, and S. Rose-John. 1992. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149:2021-2077.
15. Novick, D., H. Engelmann, M. Revel, O. Leitner, and M. Rubinstein. 1991. Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10:137-146.
16. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581.
17. Taga, T., M. Narazaki, K. Yasukawa, T. Saito, D. Miki, M. Hamaguchi, S. Davis, M. Shoybo, G.D. Yancopoulos, and T. Kishimoto. 1992. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin-6 signal transducer gp130. Proc. Natl. Acad. Sci. U.S.A. 89:10998-11001.
18. Tosato, G., and S. Pike. 1988. Interferon-beta-2/interleukin 6 is a costimulant for human T lymphocytes. J. Immunol. 141:1556-1562.
19. Uyttenhove, C., P.G. Coulie, and J. Van Snick. 1988. T cell growth and differentiation activity of interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J. Exp. Med. 167:1417-1427.
20. Verwilghen, J., M.L. Baroja, F. Van Vaeck, J. Van Damme, and J.L. Ceuppens. 1990. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: Variable dependence of interleukin-1 as a helper signal for T-cell activation. Immunology 72:269-276.
21. Yamasaki, K., T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T. Hirano, and T. Kishimoto. 1988. Cloning and expression of the human interleukin-6 (BSF-2/INF β) receptor. Science 241:825-828.
22. Zabaleta, M.E., F.I. Toro, M.E. Ruiz, C.J. Colmenares, N.E. Bianco, and I.V. Machado. 1992. Assessment of former and newly available HBV in a Third World setting. J. Med. Virol. 38:240-245.
23. Zola, H., and L. Flego. 1992. Expression of interleukin-6 receptor on blood lymphocytes without in vitro activation. Immunology 76:338-340.